• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence.

作者信息

Badamgarav Enkhe, Fitzpatrick Lorraine A

出版信息

Mayo Clin Proc. 2006 Aug;81(8):1009-12. doi: 10.4065/81.8.1009.

DOI:10.4065/81.8.1009
PMID:16901022
Abstract
摘要

相似文献

1
A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence.
Mayo Clin Proc. 2006 Aug;81(8):1009-12. doi: 10.4065/81.8.1009.
2
Adherence and persistence: impact on outcomes and health care resources.依从性和持续性：对治疗结果及医疗资源的影响
Bone. 2006 Feb;38(2 Suppl 2):S18-21. doi: 10.1016/j.bone.2005.11.013. Epub 2006 Jan 27.
3
How to prevent glucocorticoid-induced osteoporosis.如何预防糖皮质激素性骨质疏松症。
Cleve Clin J Med. 2010 Aug;77(8):529-36. doi: 10.3949/ccjm.77a.10003.
4
The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.将药物依从性纳入药物经济学分析的重要性：以骨质疏松症为例。
Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):159-66. doi: 10.1586/erp.12.8.
5
Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem.持续使用双膦酸盐治疗骨质疏松症：探寻问题根源。
Am J Med. 2006 Apr;119(4 Suppl 1):S12-7. doi: 10.1016/j.amjmed.2005.12.018.
6
How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.骨质疏松症患者如何能从治疗中获得更多益处？双膦酸盐治疗的依从性问题。
Ann Pharmacother. 2006 Jun;40(6):1143-50. doi: 10.1345/aph.1G534. Epub 2006 May 30.
7
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.提高骨质疏松症双膦酸盐治疗的依从性和持续性。
Am J Med. 2006 Apr;119(4 Suppl 1):S18-24. doi: 10.1016/j.amjmed.2005.12.019.
8
Potential clinical and economic impact of nonadherence with osteoporosis medications.骨质疏松症药物治疗不依从的潜在临床和经济影响。
Calcif Tissue Int. 2010 Mar;86(3):202-10.
9
Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis.骨质疏松症药物治疗实际依从性的系统评价与荟萃分析
Mayo Clin Proc. 2007 Dec;82(12):1493-501. doi: 10.1016/S0025-6196(11)61093-8.
10
Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.评估特立帕肽在接受抗吸收治疗时发生骨折或对先前抗吸收治疗不耐受的骨质疏松症患者中的依从性、接受度和耐受性：一项为期18个月的多中心、开放标签、前瞻性研究。
Clin Ther. 2007 Sep;29(9):2055-67. doi: 10.1016/j.clinthera.2007.09.024.

引用本文的文献

1
Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study.评价口服柠檬酸钙在老年骨质减少症患者中的依从性、耐受性和安全性：一项真实世界的、非干预性、前瞻性、多中心研究。
Aging Clin Exp Res. 2024 Feb 12;36(1):38. doi: 10.1007/s40520-024-02696-9.
2
Analysis of Influencing Factors of Medication Compliance in Patients with Recurrent Vertebral Fractures after Percutaneous Kyphoplasty and the Role of Family-Centered Education Intervention.经皮椎体后凸成形术后复发性椎体骨折患者用药依从性的影响因素分析及家庭本位教育干预的作用
Evid Based Complement Alternat Med. 2021 Oct 22;2021:3974674. doi: 10.1155/2021/3974674. eCollection 2021.
3
Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates.
静脉注射唑来膦酸与其他双膦酸盐相比在骨质疏松症治疗中的依从性和偏好性
Eur J Hosp Pharm. 2019 Jan;26(1):4-9. doi: 10.1136/ejhpharm-2017-001258. Epub 2017 Sep 20.
4
Denosumab: a review of its use in postmenopausal women with osteoporosis.地诺单抗：绝经后骨质疏松症女性使用情况综述
Drugs Aging. 2014 Jul;31(7):555-76. doi: 10.1007/s40266-014-0191-3.
5
Characteristics associated with bone mineral density responses to alendronate in men.与男性对阿伦膦酸盐的骨密度反应相关的特征。
Calcif Tissue Int. 2013 Jun;92(6):548-56. doi: 10.1007/s00223-013-9715-9. Epub 2013 Mar 15.
6
Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers.影响骨质疏松症药物治疗依从性的因素：采用焦点小组方法探讨患者和提供者的观点。
J Geriatr Phys Ther. 2011 Apr-Jun;34(2):72-81. doi: 10.1097/JPT.0b013e3181ff03b4.
7
[Osteoporosis treatment with biphosphonates: Approaches to care reality].[双膦酸盐治疗骨质疏松症：现实护理方法]
Aten Primaria. 2011 Feb;43(2):95-9. doi: 10.1016/j.aprim.2010.04.008. Epub 2010 Jun 11.
8
Treatment of postmenopausal osteoporosis, patient perspectives - focus on once yearly zoledronic acid.绝经后骨质疏松症的治疗：患者视角——聚焦每年一次的唑来膦酸
Patient Prefer Adherence. 2009 Nov 3;3:189-93. doi: 10.2147/ppa.s3494.
9
Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.患者启动骨质疏松症治疗的决策：知识与信念的影响。
J Gen Intern Med. 2008 Nov;23(11):1815-21. doi: 10.1007/s11606-008-0772-0. Epub 2008 Sep 12.
10
Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.双膦酸盐在绝经后骨质疏松症管理中的应用——优化临床实践中的疗效
Clin Interv Aging. 2008;3(2):279-97. doi: 10.2147/cia.s2134.